News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
The systemic therapy options available for mCRPC – National Comprehensive Cancer Network
Hiba Ahmad/doximity.com
Apr 22, 2025, 13:59

The systemic therapy options available for mCRPC – National Comprehensive Cancer Network

National Comprehensive Cancer Network (NCCN) shared a post on LinkedIn:

“Join us on April 28 for the Optimizing Patient Outcomes webinar on Metastatic Castration-Resistant Prostate Cancer: Systemic Therapy Updates.

Hiba Ahmad from the University of Colorado Cancer Center will summarize the systemic therapy options available for metastatic castration-resistant prostate cancer (mCRPC) and more.

Register now.”

The systemic therapy options available for mCRPC - National Comprehensive Cancer Network

cancer fight against cancer Global fight against cancer mCRPC metastatic castration-resistant prostate cancer National Comprehensive Cancer Network NCCN OncoDaily Oncology University of Colorado Cancer Center
Special Coverage
Blog
Apr 22, 2025, 14:05
Nicholas DeVito: Our first-line immunotherapy trial for advanced/metastatic CRC without liver, bone, or brain metastasis is still enrolling
Blog
Apr 22, 2025, 13:59
The systemic therapy options available for mCRPC - National Comprehensive Cancer Network
Science
Apr 22, 2025, 13:49
Joshua Brody: How to measure T-cell bystander tumor killing to prevent antigen escape after cancer immunotherapy
Blog
Apr 22, 2025, 13:34
Sampad Roy: A potential paradigm shift in breast cancer treatment
Blog
Apr 22, 2025, 13:19
IASLC Board of Directors Elections 2025: Spotlight on Undesignated Seat Candidates
Oncolibrary
Apr 22, 2025, 13:02
Trodelvy and Keytruda Achieve Breakthrough Results, Ushering in a New Era for ADCs in Breast Cancer
Radiotherapy
Apr 22, 2025, 12:05
Success Rate and Survival After Stereotactic Radiotherapy
OncoDaily Pulse
Apr 22, 2025, 11:13
New section on OncoDaily - A space that brings all career opportunities into one place
Oncolibrary
Apr 22, 2025, 11:10
DESTINY-Breast09 trial: Enhertu + Pertuzumab Improves PFS in First-Line HER2+ Metastatic Breast Cancer
Blog
Apr 22, 2025, 11:06
How immune cell baselines may predict CD22 therapy outcomes in Pediatric Cancer - NCI Center for Cancer Research
Blog
Apr 22, 2025, 10:57
Register for MASCC25 at the early bird rate - The Multinational Association of Supportive Care in Cancer
Blog
Apr 22, 2025, 10:51
Amol Akhade: Sacituzumab govitecan plus pembrolizumab shows PFS benefit in metastatic TNBC